0001398344-20-022593.txt : 20201113
0001398344-20-022593.hdr.sgml : 20201113
20201113121511
ACCESSION NUMBER: 0001398344-20-022593
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20200930
FILED AS OF DATE: 20201113
DATE AS OF CHANGE: 20201113
EFFECTIVENESS DATE: 20201113
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Essex Woodlands Management, Inc.
CENTRAL INDEX KEY: 0001542339
IRS NUMBER: 200389009
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-14839
FILM NUMBER: 201310178
BUSINESS ADDRESS:
STREET 1: 21 WATERWAY AVE
STREET 2: STE 225
CITY: THE WOODLANDS
STATE: TX
ZIP: 77380
BUSINESS PHONE: 281-364-1555
MAIL ADDRESS:
STREET 1: 21 WATERWAY AVE
STREET 2: STE 225
CITY: THE WOODLANDS
STATE: TX
ZIP: 77380
FORMER COMPANY:
FORMER CONFORMED NAME: Essex Woodlands Health Ventures, Inc.
DATE OF NAME CHANGE: 20120214
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001542339
XXXXXXXX
09-30-2020
09-30-2020
false
Essex Woodlands Management, Inc.
21 WATERWAY AVE
STE 225
THE WOODLANDS
TX
77380
13F HOLDINGS REPORT
028-14839
N
Richard Kolodziejcyk
Chief Compliance Officer and Chief Financial Officer
281-364-1555
/s/ Richard Kolodziejcyk
The Woodlands
TX
11-13-2020
0
8
188208
INFORMATION TABLE
2
fp0058553_13fhr-table.xml
13F INFORMATION TABLE
AXOGEN INC
COM
05463X106
23049
1981888
SH
SOLE
1981888
0
0
CATALYST BIOSCIENCES INC
COM NEW
14888D208
338
78622
SH
SOLE
78622
0
0
ENDOLOGIX INC
COM NEW
29266S304
3
125747
SH
SOLE
125747
0
0
EYEPOINT PHARMACEUTICALS INC
COM
30233G100
21793
41909219
SH
SOLE
41909219
0
0
MEDICINOVA INC
COM NEW
58468P206
5795
1105941
SH
SOLE
1105941
0
0
REVANCE THERAPEUTICS INC
COM
761330109
84019
3342047
SH
SOLE
3342047
0
0
TELA BIO, INC.
COM
872381108
24401
1475293
SH
SOLE
1475293
0
0
VENUS CONCEPT, INC.
COM
92332W105
28809
12417856
SH
SOLE
12417856
0
0